Cell science, processing and biobanking for translational programmes
Research platforms, quality-controlled cell services and collaboration with medical and scientific institutions across China.
A Shenzhen biotechnology company built around cell research and controlled processing.
Founded in July 2005, Beike Biotechnology operates research, cell-banking and cell-preparation capabilities in China. The figures shown here are company-reported and were last consolidated in January 2024.
About usComprehensive Cell Bank & Regional Cell Preparation Network
A network of cell-banking and preparation capabilities serving programmes across South, East, Central, North, Southwest and Northwest China. Facility, process and accreditation scope should be confirmed for each engagement.
Explore products and servicesStorage, preparation and translational research capabilities.
Each service is delivered within a defined facility, process and quality scope. Availability and permitted use depend on the programme and jurisdiction.
Latest from Beike
All news →
Important notice on guarding against the unauthorized use of the 'Beike Biotech' name in business activities
Shenzhen Beike Biotechnology Co., Ltd. issues a formal notice on the prevention of fraudulent use of the 'Beike Biotech' name in commercial activities,…
Process research from Beike Biotech's Preparation Center published in the renowned international journal Stem Cell Research & Therapy
The 2024 latest process research from Beike Biotech's Preparation Center has been published in the renowned international journal Stem Cell Research &…
Major news! Beike Biotech's in-house developed first domestic stem cell new drug for systemic lupus erythematosus approved for clinical trials
On April 28, 2024, Beike Biotech's in-house developed innovative cell drug 'Human Umbilical Cord Mesenchymal Stem Cell Injection' for the treatment of…